|

RB Liquid Biopsy Biorepository

RECRUITINGSponsored by Children's Hospital Los Angeles
Actively Recruiting
SponsorChildren's Hospital Los Angeles
Started2017-01-01
Est. completion2028-12-31
Eligibility
Age0 Years – 18 Years
Healthy vol.Accepted
Locations1 site
View on ClinicalTrials.gov →

NCT04959097

Summary

Retinoblastoma (RB) is a primary eye cancer that forms in the back of the eye of infants and toddlers. Traditionally, RB is diagnosed without a biopsy; tumor can only be studied once an eye has been surgically removed. Given this limitation, we use aqueous humor (AH), the clear fluid in the front of the eye to detect specific markers, or information, that comes from the tumor itself.

Eligibility

Age: 0 Years – 18 YearsHealthy volunteers accepted
Inclusion Criteria:

* All patients, age 0 days to 18 years, with a diagnosis unilateral or bilateral retinoblastoma (RB) seen at CHLA (Children's Hospital Los Angeles).

Exclusion Criteria:

* Patients referred for second opinions only and not treated at CHLA for any reason.

Conditions4

CancerRetinoblastomaRetinoblastoma BilateralRetinoblastoma Unilateral

Locations1 site

Children's Hospital Los Angeles
Los Angeles, California, 90027
Jesse Berry, MD323-361-4510jberry@chla.usc.edu

Browse More Trials

Cancer trials

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.